middle.news
INOVIQ’s CAR-Exosome Therapy Destroys 88% of Aggressive Cancer Cells in Lab Tests
8:55am on Wednesday 18th of June, 2025 AEST
•
Healthcare
Read Story
INOVIQ’s CAR-Exosome Therapy Destroys 88% of Aggressive Cancer Cells in Lab Tests
8:55am on Wednesday 18th of June, 2025 AEST
Key Points
CAR-exosome therapy kills 88% of TNBC and lung cancer cells in vitro
Uses engineered CAR-NK-EVs produced via proprietary EXO-ACE™ method
Potential for off-the-shelf treatment offering advantages over CAR-T therapies
Next step involves animal testing before human clinical trials
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE